PatientsVisitorsLocations & ServicesAbout the RegionJoin Our TeamPhysicians
Find:  Locations | Services
Pathology and Laboratory Medicine HomeTest and Services CatalogueTransfusion Medicine Product CataloguePolicy and ProcedureJob AidsSpecimen Collection and TransportRequisitionsAntibiogramsGenetic Testing and Molecular GeneticsMicrobiology EssentialsTransfusion EssentialsReference RangesLaboratory SuppliesAcute Care SCM GuidelinesContact InformationPhysician Access to Patient ResultsNew Clinic or Provider Information Changes
Pathology and Laboratory Medicine
Test Catalogue

​Chromosomal Microarray (aCGH)


​Ordering Recommendation

  • ​​Ordering of this test is restricted to physicians who have been granted approval by the department of Medical Genetics

​ ​Specimen Requirements

  • ​Peripheral blood/whole blood
  • Skin or other tissue
​Collection Procedure
  • ​Invert tube several times to mix
  • Specimen must be accompanied by a completed test requisition
  • Failure to include relevant patient information may result in test results being delayed or discontinued
​Required Volume

  • Optimal Volume: 4 – 7 mL
  • Minimum Volume: 2 mL
    (Submitting the minimum volume makes it impossible to repeat the test or perform confirmatory/reflex testing. In some situations, a minimum volume may require a second collection.)
  • Pediatric Volume: 2 mL of peripheral blood or cord blood
  • 0.5 cm x 0.5 cm skin specimen
  • Blocks are accepted as received
  • ​Ship specimens at ambient temperature
  • Specimens may be stored at 2 – 8 ° C
Grounds for Rejection​

Testing Information​ ​

  • ​Specimens accepted Monday to Friday, 8:00 am to 5:00 pm in the Cytogenetics Laboratory
  • STAT tests are sent to Calgary within 7 days of specimen receipt
Testing Site​
  • Alberta Children’s Hospital, Calgary, AB 
Results Reporting​
  • ​Turnaround time for routine test is 28 days
  • Turnaround time for STAT is 14 days
​Reflex Testing
  • ​Reflex testing after abnormal microarray results will require either FISH by cytogenetics or qPCR by molecular methods for confirmation of array results and/or follow-up for family members
  • ​DNA is banked on all microarray specimens. Banked DNA will be stored at RRPL. Should further genetic testing be needed, please see Genetic Testing/Molecular Genetics
  • Infinium CyoSNP-850K v1.2 bead chip
​Clinical Interpretation
  • The array CGH technology detects gains or losses of targeted DNA sequences including aneuploidy, with high accuracy and sensitivity. It does not detect gains or losses of non-tested sequences, balanced chromosomal rearrangements such as balanced translocations or balanced inversions, point mutations, polyploidy or abnormalities of repetitive sequences and it does not reliably detect mosaicism. Failure to detect a copy number alteration at any locus does not rule out the diagnosis since disorders represented on the array can be caused by other genetic mechanisms 
  • Anomaly designation follows the most recent edition of the International System for Human Cytogenetic Nomenclature
​Specimen Retention
  • ​Banked DNA is retained for 50 years
Alternate Test Names​
  • Array
​Additional Comments
  • ​Specimens are batched and shipped to Calgary on Wednesdays; STAT specimens are shipped on other days if necessary
​SHR LIS Test Code
  • ​PB, MG (For Lab Use Only)

Testing Ordering Requirements​ ​

​Preferred Specimen Collection
  • ​Selective Test Centre at RUH or on ward
​Forms Required
​Clearance Required
  • ​Pediatricians are pre-approved to order microarray testing
  • if the requisition is incomplete or the test is ordered by a physician who is not approved, DNA will be extracted and sent to RRPL for banking until testing can proceed
  • If you require any other genetic test refer to Genetic testing/Molecular genetics for ordering information
  • If planning to request testing or if the specimen has already been collected, DNA banking can be requested until approval can be obtained from Medical Genetics

Patient History​ ​

​Relevant Clinical History
  • Developmental Delay/MR               
  • Prenatal growth retardation
  • Postnatal growth anomalies
  • Dysmorphic features
  • Congenital anomalies
  • Neurological issues

​If you choose to print this information, it is valid only on date of print.

Laboratory Controlled Document LSM-929 v3

Last Modified: Tuesday, October 8, 2019 |
Questions or feedback about this page?